Research Article
Total Bilirubin Predicts Severe Progression of Diabetic Retinopathy and the Possible Causal Mechanism
Table 1
Demographic and metabolism characterization of study subjects.
| Group | Progression group () | Stable group () | // value | value |
| General data | | | | | Gender (male/female) | 32/35 | 224/249 | 0.004 | 0.951 | Age (year) | | | 0.657 | 0.512 | Average follow-up time (month) | 49 (40–56) | 47 (38–54) | 0.301 | 0.743 | Duration of diabetes (year) | | | 4.46 | <0.001 | Type of diabetes (T1DM/T2DM) | 19/48 | 93/380 | 2.79 | 0.248 | Glucose metabolism | | | | | FPG (mmol/l) | | | 1.985 | 0.048 | HbA1c (%) | | | 0.104 | 0.917 | Biochemical data | | | | | ALT (IU/l) | 18 (13–24) | 16 (10–22) | 0.258 | 0.784 | AST (IU/l) | 17 (9-26) | 17 (8-30) | 0.135 | 0.876 | TBIL (μmol/l) | | | 6.450 | <0.001 | DBIL (μmol/l) | | | 6.992 | <0.001 | IBIL (μmol/l) | | | 2.427 | 0.016 | Γ-GT (IU/l) | 18 (14–27) | 19 (15–30) | 0.368 | 0.697 | ALP (IU/l) | 102 (72–140) | 92 (83–147) | 1.368 | 0.205 | Cr (μmol/l) | 86 (32–102) | 81 (37–98) | 1.231 | 0.274 | eGFR (ml/min/1.73 m2) | | | 0.609 | 0.543 | CKD stage (number) | | | 0.333 | 0.954 | G1 | 12 | 97 | | | G2 | 23 | 162 | | | G3a | 18 | 125 | | | G3b | 14 | 89 | | | Urine protein categories (number) | | | 0.395 | 0.821 | Normoalbuminuria | 39 | 287 | | | Microalbuminuria | 21 | 147 | | | Macroalbuminuria | 7 | 39 | | |
|
|